Novo Nordisk increases transparency on tax payments

Due to a shift in Novo Nordisk's tax reporting policy, the firm will prospectively be more transparent about its global tax payments, states head of tax Camilla Wright.

Photo: Stine Tidsvilde

Danish pharmaceutical company Novo Nordisk is increasing its transparency on company tax payments, and in the future it will report on more detailed information from single markets in which the firm operates, according to Danish financial media Økonomisk Ugebrev.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs